Briefing
Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance
A companion analysis focused on the negative predictive value of circulating TTMV-HPV DNA during surveillance of HPV-driven oropharyngeal cancer.
- Design: Evidence level 2
- Assay: Not named in the abstract
Clin Cancer ResPubMed 37566241DOI 10.1158/1078-0432.CCR-23-1478